ARWR
Arrowhead Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $4.90B | Price | $42.39 |
| Volume | 1.72M | Change | +0.19% |
| P/E Ratio | -8.2 | Open | $42.32 |
| Revenue | $3.6M | Prev Close | $42.31 |
| Net Income | $-599.5M | 52W Range | $9.57 - $43.69 |
| Div Yield | N/A | Target | $45.08 |
| Overall | 75 | Value | 60 |
| Quality | -- | Technical | 90 |
No chart data available
Stock Overview
Updated DailyArrowhead Pharmaceuticals Inc. (ARWR) is a leading diversified company in the Biotechnology industry, currently trading at $42.39 with a market capitalization of $4.90 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ARWR with a volume of 1.72 million shares. The stock opened up 0.02% from yesterday's close of $42.31. Current analyst estimates project earnings of $-0.11 per share for this year, with next year targeting $-2.28.
ARWR demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ALNY, LGND, JNJ, INO, NANX.
Key investment considerations for ARWR include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 6.3%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:49 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARWR | $42.39 | +0.2% | 1.72M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arrowhead Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW